BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 9664945)

  • 1. Low-dose tacrolimus (FK506)-based immunosuppressive protocol in living donor renal transplantation.
    Kokado Y; Takahara S; Kyo M; Ichimaru N; Jing-Ding W; Miki T; Okuyama A
    Transpl Int; 1998; 11 Suppl 1():S60-4. PubMed ID: 9664945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A multicenter analysis of the first experience with FK506 for induction and rescue therapy after pancreas transplantation.
    Gruessner RW; Burke GW; Stratta R; Sollinger H; Benedetti E; Marsh C; Stock P; Boudreaux JP; Martin M; Drangstveit MB; Sutherland DE; Gruessner A
    Transplantation; 1996 Jan; 61(2):261-73. PubMed ID: 8600635
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506 (tacrolimus) compared with cyclosporine for primary immunosuppression after pediatric liver transplantation. Results from the U.S. Multicenter Trial.
    McDiarmid SV; Busuttil RW; Ascher NL; Burdick J; D'Alessandro AM; Esquivel C; Kalayoglu M; Klein AS; Marsh JW; Miller CM
    Transplantation; 1995 Feb; 59(4):530-6. PubMed ID: 7533345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival.
    Jiang H; Sakuma S; Fujii Y; Akiyama Y; Ogawa T; Tamura K; Kobayashi M; Fujitsu T
    Transpl Int; 1999; 12(2):92-9. PubMed ID: 10363590
    [TBL] [Abstract][Full Text] [Related]  

  • 5. FK506 effectiveness in reducing acute rejection after heart transplantation: a prospective randomized study.
    Rinaldi M; Pellegrini C; Martinelli L; Goggi C; Gavazzi A; Campana C; Arbustini E; Grossi P; Regazzi M; Ippoliti G; Vigano M
    J Heart Lung Transplant; 1997 Oct; 16(10):1001-10. PubMed ID: 9361242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prospective clinical trial comparing two immunosuppressive regimens, tacrolimus and mycophenolate mofetil versus everolimus and low-dose cyclosporine, in de novo renal transplant recipients: results at 6 months follow-up.
    Favi E; Citterio F; Spagnoletti G; Gargiulo A; Delreno F; Romagnoli J; Castagneto M
    Transplant Proc; 2009 May; 41(4):1152-5. PubMed ID: 19460503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rescue therapy with tacrolimus after combined kidney/pancreas and isolated pancreas transplantation in patients with severe cyclosporine nephrotoxicity.
    Hariharan S; Munda R; Cavallo T; Demmy AM; Schroeder TJ; Alexander JW; First MR
    Transplantation; 1996 Apr; 61(8):1161-5. PubMed ID: 8610411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Outcomes of Living-Donor Kidney Transplantation With Immunosuppression Therapy Induction With Tacrolimus Extended-Release: A Comparison With Cyclosporine.
    Konno O; Yokoyama T; Kihara Y; Nakamura Y; Ueno T; Takeuchi H; Iwamoto H
    Transplant Proc; 2018 Oct; 50(8):2457-2460. PubMed ID: 30316378
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An open-label, concentration-ranging trial of FK506 in primary kidney transplantation: a report of the United States Multicenter FK506 Kidney Transplant Group.
    Laskow DA; Vincenti F; Neylan JF; Mendez R; Matas AJ
    Transplantation; 1996 Oct; 62(7):900-5. PubMed ID: 8878381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunosuppressive treatment of primary cadaveric renal transplant patients receiving kidneys from non-heart beating donors.
    Ohshima S; Fujita T; Ono Y; Kinukawa T; Katoh N; Matsuura O
    Artif Organs; 1996 Oct; 20(10):1130-6. PubMed ID: 8896734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rescue immunosuppressive therapies in living-related renal allotransplant: a long-term prospective randomized evaluation.
    Bakr MA; Gheith OA; Ismael AM; Baz ME; Shehab El-Dein AB; Ghoneim MA
    Exp Clin Transplant; 2008 Mar; 6(1):48-53. PubMed ID: 18405245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral tacrolimus (FK506) induction therapy in pediatric orthotopic liver transplantation.
    Cacciarelli TV; Esquivel CO; Cox KL; Hayashi M; Berquist WE; Concepcion W; So SK
    Transplantation; 1996 Apr; 61(8):1188-92. PubMed ID: 8610416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-dose mizoribine combined with calcineurin inhibitor (cyclosporine or tacrolimus), basiliximab and corticosteroids for renal transplantation: A Japanese multicenter study.
    Nishioka T; Yoshimura N; Ushigome H; Watarai Y; Nishimura K; Akioka K; Nakamura N; Kawakita M; Yuzawa K; Nakatani T
    Int J Urol; 2018 Feb; 25(2):141-145. PubMed ID: 29068092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. How best to use tacrolimus (FK506) for treatment of steroid- and OKT3-resistant rejection after renal transplantation.
    Eberhard OK; Kliem V; Oldhafer K; Schlitt HJ; Pichlmayr R; Koch KM; Brunkhorst R
    Transplantation; 1996 May; 61(9):1345-9. PubMed ID: 8629294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of FK506- and cyclosporine-based immunosuppression in primary orthotopic liver transplantation. A single center experience.
    Neuhaus P; Blumhardt G; Bechstein WO; Platz KP; Jonas S; Mueller AR; Langrehr JM; Lohmann R; Schattenfroh N; Knoop M
    Transplantation; 1995 Jan; 59(1):31-40. PubMed ID: 7530868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. One-year follow-up of an open-label trial of FK506 for primary kidney transplantation. A report of the U.S. Multicenter FK506 Kidney Transplant Group.
    Vincenti F; Laskow DA; Neylan JF; Mendez R; Matas AJ
    Transplantation; 1996 Jun; 61(11):1576-81. PubMed ID: 8669100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized clinical trial of the effect of microemulsion cyclosporin and tacrolimus on renal allograft fibrosis.
    Murphy GJ; Waller JR; Sandford RS; Furness PN; Nicholson ML
    Br J Surg; 2003 Jun; 90(6):680-6. PubMed ID: 12808614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study of tacrolimus in postoperative treatment of patients with renal transplantation for diabetic end-stage renal disease].
    Yu LX; Shan HT; Fu SJ; Du CF; Ma JJ; Xu J; Deng WF; Wang YB
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Nov; 23(11):1146-8. PubMed ID: 14625173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group.
    Pirsch JD; Miller J; Deierhoi MH; Vincenti F; Filo RS
    Transplantation; 1997 Apr; 63(7):977-83. PubMed ID: 9112351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.